Geron | GERN - Ordinary Share Capital


Geron reported $638.02M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Amgen USD 538M 300K Sep/2025
Bio Techne USD 155.75M 154.18M Sep/2025
Cassava Sciences USD 48.31M 48.26M Sep/2025
Cytokinetics USD 122.12M 2.52M Sep/2025
Exelixis USD 268.1M 2.03M Sep/2025
Genmab DKK 10M 56M Mar/2025
Geron USD 638.02M 637.38M Sep/2025
Gilead Sciences USD 1.24B 0 Sep/2025
Incyte USD 196.13M 2.01M Sep/2025
MacroGenics USD 63.26M 62.63M Sep/2025
Novartis USD 1.94B 23.4M Jun/2025